Complex ANDAs: Early Meetings With FDA Can Generate Bonus Communication

 
• By Derrick Gingery
FDAEntrance_1200x675
FDA outlines formal meeting process for sponsors of complex generic drugs.

More from Generics

More from Biosimilars & Generics